Vanguard Global Advisers
MDT icon

Vanguard Global Advisers’s Medtronic MDT Stock Holding History

Vanguard Global Advisers’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$224M Sell
2,865,007
-3,607
-0.1% -$291K 0.1% 134
2026
Q1 		$249M Buy
+2,868,614
New +$275M 0.13% 118

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Global Advisers's MDT Position: Q2 2026 in Review

Vanguard Global Advisers reduced its Medtronic (MDT) stake by 0.13% in Q2 2026, selling an estimated $291K and leaving 2,865,007 shares worth $224M. The position accounts for 0.1% of the portfolio, ranked #134.

Vanguard Global Advisers first reported a position in MDT in Q1 2026 and has held it in 2 quarters since. The position peaked at $249M in Q1 2026. 2,044 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Vanguard Global Advisers held 2,865,007 shares of Medtronic worth $224M as of Q2 2026.
  • Vanguard Global Advisers sold 3,607 Medtronic shares in Q2 2026, an estimated $291K.
  • Medtronic made up 0.1% of Vanguard Global Advisers's portfolio in Q2 2026, its #134 holding.
  • Vanguard Global Advisers first reported a position in Medtronic in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's Medtronic position peaked at $249M in Q1 2026.
  • 2,044 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.